Preferred Label : hTERT mRNA/Survivin Peptide-double-loaded Autologous Dendritic Cell Vaccine;
NCIt definition : A cancer vaccine containing autologous dendritic cells (DCs) that are pulsed with
mRNA encoding human telomerase reverse transcriptase (hTERT) and survivin peptide,
with potential immunostimulatory and antineoplastic activities. Upon administration,
hTERT mRNA/survivin peptide-double-loaded autologous dendritic cell vaccine may elicit
an immune response against cancer cells expressing hTERT and survivin by activating
cytotoxic T-cells (CTLs), natural killer cells (NKs), and B-lymphocytes. The tumor
associated antigens (TAAs) hTERT, the catalytic subunit of human telomerase, and survivin,
a member of the inhibitor of apoptosis (IAP) family of proteins, may be upregulated
in certain tumor cell types and play key roles in tumor cell growth and survival.;
Drug name : Procure;
NCI Metathesaurus CUI : CL432938;
Origin ID : C99116;
UMLS CUI : C3274539;
Semantic type(s)
- concept_is_in_subset
